Pathos stock

Pathos Stock

HealthTech

Looking to sell Pathos stock or options?

Founded: 2022Funding to Date: $104Mhttps://www.pathos.com

Pathos has developed a drug discovery platform designed to shorten the medication development timeline. The company's innovative platform leverages big data, technology, and artificial intelligence to identify targets, validate them, and confirm their clinical efficacy. This approach enables drug developers to explore novel ideas and advance groundbreaking therapies for cancer and other diseases.

Investors Include:

New Enterprise Associates, Revolution Group, Eric Lefkofsky, Lightbank (Service Provider), Builders VC, Revolution (Washington DC).

Own Pathos stock or options?

Get an instant valuation

  • Completely free
  • 100% confidential & secure
  • Takes less than a minute
100% private & secure